Law360, San Francisco (May 18, 2011, 7:35 PM ET) -- Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday lost bids to disqualify two expert witnesses and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.
U.S. District Judge Thomas W. Thrash Jr. said Solvay hadn't produced specific enough evidence or communications showing that plaintiffs' expert Dr. Howard Maibach received confidential information related to underlying patent litigation over the hormone drug while retained by Heim Payne & Chorush LLP and Garwin Gerstein & Fisher LLP.
The judge...
Firms, Experts Allowed To Stay In AndroGel MDL
To view the full article, take a free trial now.
